HIFU is performed without the benefit of real-time, first-hand visualization. Like other prostate cancer treatments, such as CyberKnife® radiation, pre-treatment from PSA testing, prostate biopsy, CT scans, and real-time imaging are used by doctors to approximate the target for theultrasound.
Unfortunately, the data available prior to treatment can be very limited and is not always accurate. It is not until the prostate is seen first hand during robotic surgery, and tested after surgery, that the true extend of the prostate cancer is known. The type of prostate cancer, the shape and size of the tumor, and the exact location cannot be established with certainly from biopsy and scans, or from computer imaging. Surgery also affords the opportunity to fully assess the status of the lymph nodes and the seminal vesicles for any presence of cancer.
The long-term success of HIFU in eliminating prostate cancer is unknown. Further study is needed to determine whether addressing the cancerous tissue alone, and leaving the prostate intact, is aggressive enough to provide long-term wellness and quality of life. Dr. Samadi’s robotic prostate removal surgery eliminates some of this concern, as the prostate and all visible cancerous tissue is removed from the body.
As such, HIFU may be a better prostate cancer treatment option for men who are not surgical candidates or who have undergone previous procedures, such as radiation, and are facing recurrence of their prostate cancer.
With robotic prostatectomy surgery, men are offered greater piece of mind through the complete removal of the cancerous prostate. Dr. Samadi is highly experienced in this minimally invasive prostate removal surgery. His expert judgment, paired with the first-hand visual knowledge he gathers during the procedure optimizes the surgical outcomes.
Just six weeks after robotic prostatectomy surgery, men who adhere to Dr. Samadi’s post-surgical care and follow-up should have an undetectable PSA level.
HIFU risks are increased each time the procedure is performed.
Long-term HIFU impotence risk:
Some reports indicate that as many as 70% of men are left impotent after HIFU due to risk of damage to the tiny nerves responsible for erectile function. In contrast, with optimal patient conditions, surgical results, and post-operative care only 15% of Dr. Samadi’s patients manage the same concern.
Men considering HIFU for prostate cancer should be aware that its long-term effectiveness and comprehensive risks are not yet proven.